EONS/ESMO Biosimilars survey

In cancer care biosimilars are introduced and as patents will expire from innovator biologics, more biosimilars are arriving to use. The European Oncology Nursing Society (EONS) and the European Society for Medical Oncology (ESMO) would like to collect information to understand the current knowledge, use and acceptance of biosimilars in cancer nursing.  They also want to know, whether there is a need for additional cancer nurse support and training on biosimilars in cancer treatment.

Therefore, it would be fantastic if you could find the time for taking this 10 minutes survey.

 

Jaa artikkeli: